Pharmacosmos As Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PHARMACOSMOS AS, and when can generic versions of PHARMACOSMOS AS drugs launch?
PHARMACOSMOS AS has one approved drug.
There are three US patents protecting PHARMACOSMOS AS drugs.
There are forty-eight patent family members on PHARMACOSMOS AS drugs in twenty-five countries and one supplementary protection certificate in one country.
Summary for Pharmacosmos As
International Patents: | 48 |
US Patents: | 3 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 5 |
Drugs and US Patents for Pharmacosmos As
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-002 | Jan 16, 2020 | DISCN | Yes | No | 8,815,301 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-002 | Jan 16, 2020 | DISCN | Yes | No | 10,414,831 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-003 | Jan 16, 2020 | RX | Yes | Yes | 11,633,489 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-001 | Jan 16, 2020 | DISCN | Yes | No | 11,633,489 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-003 | Jan 16, 2020 | RX | Yes | Yes | 10,414,831 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-001 | Jan 16, 2020 | DISCN | Yes | No | 8,815,301 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-001 | Jan 16, 2020 | DISCN | Yes | No | 10,414,831 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Pharmacosmos As Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 101580348 | ⤷ Try a Trial |
European Patent Office | 3821910 | ⤷ Try a Trial |
Cyprus | 1118725 | ⤷ Try a Trial |
Philippines | 12015500891 | ⤷ Try a Trial |
South Africa | 201707463 | ⤷ Try a Trial |
Lithuania | 3156075 | ⤷ Try a Trial |
Eurasian Patent Organization | 023917 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Pharmacosmos As Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2411053 | C02411053/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: FERRUM (III) UT FERRI ISOMALTOSIDUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67001 26.08.2019 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.